Changes in bacterial and fungal ocular flora of clinically normal horses following experimental application of topical antimicrobial or antimicrobial-corticosteroid ophthalmic preparations.
OBJECTIVE
To determine effects of topical antimicrobial and antimicrobial-corticosteroid preparations on the ocular flora of horses. animals: 40 horses.


METHODS
One eye was treated 3 times daily for 2 weeks with one of the following ointments: (1) neomycin-bacitracin-polymyxin B, (2) 0.6% prednisolone-0.3% gentamicin, (3) neomycin-polymyxin B-0.05% dexamethasone, or (4) treated (artificial tears) control. Contralateral eyes of treated control eyes served as untreated control eyes. Corneal and conjunctival specimens for bacterial and fungal cultures were collected prior to initiation of treatment, after 1 and 2 weeks of treatment, and 2 weeks after concluding treatment. Changes in culture growth quantity scores of bacterial and fungal species were analyzed.


RESULTS
The most common species before treatment were the following: gram-positive bacteria included Streptomyces spp (66%), Staphylococcus spp (46%), Bacillus spp (32%), and Streptococcus spp (32%); gram-negative bacteria included Moraxella spp (28%), Escherichia coli (24%), Acinetobacter spp (18%), and Enterobacter spp (14%); and fungi included Aspergillus nidulans (56%), Cladosporium spp (32%), and Aspergillus fumigatus (22%). In all groups, the percentage of positive bacterial culture results, growth quantity score of gram-positive bacteria, and number of bacterial species isolated decreased at week 1 and increased at week 2, whereas growth quantity score of gram-negative bacteria decreased throughout treatment. Differences were not significant among groups. Fungal growth quantity score decreased during treatment in all groups. Repopulation of bacterial and fungal species occurred.


CONCLUSIONS
All interventions decreased the number of microorganisms. Repopulation of normal flora occurred during and after treatment.
Gemensky-Metzler
Anne J
AJ
Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA.
Wilkie
David A
DA
Kowalski
Joseph J
JJ
Schmall
L Michael
LM
Willis
A Michelle
AM
Yamagata
Maya
M
D000287:Administration, Topical; D000818:Animals; D000891:Anti-Infective Agents, Local / Q000494:pharmacology*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001414:Bacitracin / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects*; D003907:Dexamethasone / Q000494:pharmacology; D004334:Drug Administration Schedule; D004338:Drug Combinations; D005123:Eye / Q000382:microbiology*; D005260:Female; D005658:Fungi / Q000187:drug effects*; D005839:Gentamicins / Q000494:pharmacology; D006736:Horses / Q000382:microbiology*; D008297:Male; D009355:Neomycin / Q000494:pharmacology; D011112:Polymyxin B / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology
D000891:Anti-Infective Agents, Local; D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D005839:Gentamicins; D001414:Bacitracin; D003907:Dexamethasone; D011239:Prednisolone; D009355:Neomycin; D011112:Polymyxin B